Which ASX 200 share would I buy with $10,000 today?

I think investors could be overlooking some of the ways this business can keep growing its earnings.

If I had $10,000 to invest in an S&P/ASX 200 Index (ASX: XJO) share today, one company would be near the top of my shopping list.

That company is Sigma Healthcare Ltd (ASX: SIG).

The business behind Chemist Warehouse has become one of Australia's largest healthcare companies, and I think there's still plenty of growth ahead.

Woman using her laptop with her feet up.

Image source: Getty Images

More than just Chemist Warehouse

Most investors probably associate Sigma with Chemist Warehouse's bright yellow stores and heavily discounted products.

However, the company's pharmaceutical distribution network is another important part of the investment case.

During FY26, Sigma distributed more than 579 million units to over 2,500 pharmacy customers across Australia. And after handling 6.5% more products than a year earlier, its distribution cost per unit declined.

I think that demonstrates the benefits of having such a large operation. As volumes increase, Sigma can spread its operating costs across more products, potentially improving profitability.

The company is also streamlining its distribution centres and eliminating duplicated transport costs following the Chemist Warehouse merger.

Management has already delivered $32.6 million in annual integration benefits and is targeting $100 million annually by FY29.

That's a meaningful opportunity to grow its net profit after tax without relying entirely on opening more pharmacies.

Its online business is another growth driver

Something else that has caught my attention is the performance of Chemist Warehouse's online operations.

During FY26, online revenue increased 16%, supported by a 22% increase in customer orders.

But what I found more interesting was how customers are choosing to receive their purchases. More than 80% of online sales are now fulfilled through Click & Collect.

I think this highlights another advantage of Chemist Warehouse's enormous physical presence.

Customers can browse products online, place orders, and conveniently collect them from their local pharmacy. And once they're in-store, there's always the possibility they'll purchase something else.

With Sigma continuing to invest in personalisation, search, and online fulfilment, I think its digital operations could become an increasingly important driver of growth.

The growth continues

Perhaps the strongest reason I would buy this ASX 200 share is that its growth momentum remains impressive.

In October, management revealed that Australian Chemist Warehouse branded stores had increased sales by 12.1% since the start of FY27.

Even more encouragingly, like-for-like sales increased 9.8%. This suggests the company is continuing to attract more customer spending from its existing stores, rather than relying solely on expansion.

International sales were also up 30.2% in the first quarter.

And with new stores planned across Australia and overseas, I think Sigma has plenty of opportunities to maintain this momentum.

Foolish takeaway

I think Sigma offers an attractive combination of established market positions and long-term growth potential.

Its pharmacy network is already enormous, but management is finding ways to generate more sales while improving efficiency across the business.

Of course, there's a risk that investors could pay too much for that growth, and the company still has plenty of work ahead integrating its operations.

Nevertheless, if I were investing $10,000 in a single ASX 200 share with a 10-year horizon, I would be happy to back Sigma.

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Happy businessman fist pumping while looking at a tablet.
Blue Chip Shares

Why I'm not buying CBA shares but would sell everything to buy one ASX stock

I think this stock could outperform the big four bank.

Read more »

Mid-aged couple looking at a laptop.
Blue Chip Shares

I'd buy CBA and BHP shares. But I'd buy this ASX blue chip first

Two of Australia's biggest companies would be on my buy list, but there's another share I'd put ahead of both.

Read more »

Couple on their laptop in their home kitchen.
Blue Chip Shares

I'd rather buy these 3 ASX shares than Commonwealth Bank

I'm a big fan of the banking giant but not its valuation.

Read more »

A man and woman watch their device screens, making investing decisions at home.
Blue Chip Shares

If I could choose only one, would I buy Telstra or Wesfarmers shares?

I like both businesses, but if I could only add one to my portfolio today, there's a clear reason behind…

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Blue Chip Shares

Why I'd buy Wesfarmers and Coles shares today

These businesses aren't trading at bargain prices, but I think their long-term opportunities justify a closer look.

Read more »

Happy young couple riding a motorbike together.
Blue Chip Shares

Why I'd buy these ASX blue-chip shares until at least 2036

I'm looking at three established businesses that could become more profitable over the next 10 years.

Read more »

Blue chips with stock written on them.
Blue Chip Shares

2 ASX blue-chip shares offering large dividend yields

I think these businesses have a very compelling future.

Read more »

Three smiling corporate people examine a model of a new building complex.
Blue Chip Shares

3 popular ASX shares I'd happily buy and hold until 2036

Wondering where to invest for the long term? I have my eyes on these shares.

Read more »